Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT)
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The PUMP-IT study is designed to prove the feasibility of HAIP chemotherapy with concomitant
standard systemic chemotherapy (FOLFOX and FOLFIRI) in the Netherlands. This study will
include patients with both unresectable CRLM and resectable CRLM with an indication for
upfront systemic therapy (further referred to as potentially resectable CRLM), without
extrahepatic metastases. The study will be performed in two tertiary referral centers in the
Netherlands.